Sigma Planning’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRMD
Sigma Planning's CRMD Position: Q3 2026 in Review
Sigma Planning increased its CorMedix (CRMD) stake by 8.5% in Q3 2026, buying an estimated $20.3K and bringing the position to 32,142 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #1141.
Sigma Planning first reported a position in CRMD in Q1 2024 and has held it in 11 quarters since. The position peaked at $337K in Q2 2025. 144 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.
- Sigma Planning held 32,142 shares of CorMedix worth $247K as of Q3 2026.
- Sigma Planning bought 2,531 CorMedix shares in Q3 2026, an estimated $20.3K.
- CorMedix made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #1141 holding.
- Sigma Planning first reported a position in CorMedix in Q1 2024 and has held it in 11 quarters since.
- Sigma Planning's CorMedix position peaked at $337K in Q2 2025.
- 144 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.